Human Genome Epidemiology Literature Finder
|
Records 1 - 8 (of 8 Records) |
| Query Trace: Hearing Loss and TPMT[original query] |
|---|
| Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy. Nature genetics 2009 Dec 41 (12): 1345-9. Ross Colin J D, Katzov-Eckert Hagit, Dubé Marie-Pierre, Brooks Beth, Rassekh S Rod, Barhdadi Amina, Feroz-Zada Yassamin, Visscher Henk, Brown Andrew M K, Rieder Michael J, Rogers Paul C, Phillips Michael S, Carleton Bruce C, Hayden Michael R, |
| Replication of TPMT and ABCC3 genetic variants highly associated with cisplatin-induced hearing loss in children. Clinical pharmacology and therapeutics 2013 Aug 94 (2): 243-51. Pussegoda K, Ross C J, Visscher H, Yazdanpanah M, Brooks B, Rassekh S R, Zada Y F, Dubé M-P, Carleton B C, Hayden M R, |
| Influence of genetic variants in TPMT and COMT associated with cisplatin induced hearing loss in patients with cancer: two new cohorts and a meta-analysis reveal significant heterogeneity between cohorts. PloS one 2014 9 (12): e115869. Hagleitner Melanie M, Coenen Marieke J H, Patino-Garcia Ana, de Bont Eveline S J M, Gonzalez-Neira Anna, Vos Hanneke I, van Leeuwen Frank N, Gelderblom Hans, Hoogerbrugge Peter M, Guchelaar Henk-Jan, Te Loo Maroeska W |
| TPMT, COMT and ACYP2 genetic variants in paediatric cancer patients with cisplatin-induced ototoxicity. Pharmacogenetics and genomics 2017 Apr . Thiesen Signe, Yin Peng, Jorgensen Andrea L, Zhang Jieying E, Manzo Valentina, McEvoy Laurence, Barton Christopher, Picton Susan, Bailey Simon, Brock Penelope, Vyas Harish, Walker David, Makin Guy, Bandi Srinivas, Pizer Barry, Hawcutt Daniel B, Pirmohamed Mun |
| [The analysis of the association of the polymorphic variants of the TPMT, COMT, and ABCC3 genes with the development of hearing disorders induced by the cisplatin treatment]. Vestnik otorinolaringologii 2018 83 (4): 60-66. Mironovich O L, Bliznetz E A, Garbaruk E S, Belogurova M B, Subora N V, Varfolomeeva S R, Kachanov D Yu, Shamanskaya T V, Markova T G, Polyakov A |
| Clinical and genetic associations for carboplatin-related ototoxicity in children treated for retinoblastoma: A retrospective noncomparative single-institute experience. Pediatric blood & cancer 2018 1 65 (5): e26931. Soliman Sameh E, D'Silva Crystal N, Dimaras Helen, Dzneladze Irakli, Chan Helen, Gallie Brenda |
| Association of candidate pharmacogenetic markers with platinum-induced ototoxicity: PanCareLIFE dataset. Data in brief 2020 9 32 106227. Langer Thorsten, Clemens Eva, Broer Linda, Maier Lara, Uitterlinden André G, de Vries Andrica C H, van Grotel Martine, Pluijm Saskia F M, Binder Harald, Mayer Benjamin, von dem Knesebeck Annika, Byrne Julianne, van Dulmen-den Broeder Eline, Crocco Marco, Grabow Desiree, Kaatsch Peter, Kaiser Melanie, Spix Claudia, Kenborg Line, Winther Jeanette F, Rechnitzer Catherine, Hasle Henrik, Kepak Tomas, van der Kooi Anne-Lotte F, Kremer Leontien C, Kruseova Jarmila, Bielack Stefan, Sorg Benjamin, Hecker-Nolting Stefanie, Kuehni Claudia E, Ansari Marc, Kompis Martin, van der Pal Heleen J, Parfitt Ross, Deuster Dirk, Matulat Peter, Tillmanns Amelie, Tissing Wim J E, Beck Jörn D, Elsner Susanne, Am Zehnhoff-Dinnesen Antoinette, van den Heuvel-Eibrink Marry M, Zolk Oliver, |
| Role of Cisplatin Dose Intensity and TPMT Variation in the Development of Hearing Loss in Children. Therapeutic drug monitoring 2023 3 . Siemens Angela, Brooks Beth, Rassekh S Rod, Meijer Annelot J M, van den Heuvel-Eibrink Mary M, Xu Wei, Loucks Catrina M, Ross Colin J D, Carleton Bruce C, |
- Page last reviewed:Feb 1, 2024
- Content source: